Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes.
Zhou Y, Wang X, Sun L, Zhou L, Ma TC, Song L, Wu JG, Li JL, Ho WZ.
Zhou Y, et al. Among authors: zhou l.
FASEB J. 2016 Dec;30(12):4132-4140. doi: 10.1096/fj.201600696R. Epub 2016 Sep 7.
FASEB J. 2016.
PMID: 27605546
Free PMC article.
These findings suggest a novel antiviral mechanism in liver innate immunity against HCV infection and provide insights to support further studies on developing exosome-based delivery system for disease treatment.-Zhou, Y., Wang, X., Sun, L., Zhou, L., Ma, T.- …
These findings suggest a novel antiviral mechanism in liver innate immunity against HCV infection and provide insights to support further st …